<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35844548</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>19</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Activation of the AIM2 Receptor in Circulating Cells of Post-COVID-19 Patients With Signs of Lung Fibrosis Is Associated With the Release of IL-1&#x3b1;, IFN-&#x3b1; and TGF-&#x3b2;.</ArticleTitle><Pagination><StartPage>934264</StartPage><MedlinePgn>934264</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">934264</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2022.934264</ELocationID><Abstract><AbstractText>Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), responsible for COVID-19, has caused a global pandemic. Observational studies revealed a condition, herein called as Long-COVID syndrome (PC), that affects both moderately and severely infected patients, reducing quality-of-life. The mechanism/s underlying the onset of fibrotic-like changes in PC are still not well defined. The goal of this study was to understand the involvement of the Absent in melanoma-2 (AIM2) inflammasome in PC-associated lung fibrosis-like changes revealed by chest CT scans. Peripheral blood mononuclear cells (PBMCs) obtained from PC patients who did not develop signs of lung fibrosis were not responsive to AIM2 activation by Poly dA:dT. In sharp contrast, PBMCs from PC patients with signs of lung fibrosis were highly responsive to AIM2 activation, which induced the release of IL-1&#x3b1;, IFN-&#x3b1; and TGF-&#x3b2;. The recognition of Poly dA:dT was not due to the activation of cyclic GMP-AMP (cGAMP) synthase, a stimulator of interferon response (cGAS-STING) pathways, implying a role for AIM2 in PC conditions. The release of IFN-&#x3b1; was caspase-1- and caspase-4-dependent when AIM2 was triggered. Instead, the release of pro-inflammatory IL-1&#x3b1; and pro-fibrogenic TGF-&#x3b2; were inflammasome independent because the inhibition of caspase-1 and caspase-4 did not alter the levels of the two cytokines. Moreover, the responsiveness of AIM2 correlated with higher expression of the receptor in circulating CD14+ cells in PBMCs from patients with signs of lung fibrosis.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Colarusso, Terlizzi, Maglio, Molino, Candia, Vitale, Hansbro, Vatrella, Pinto and Sorrentino.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Colarusso</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of Salerno, Fisciano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terlizzi</LastName><ForeName>Michela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of Salerno, Fisciano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maglio</LastName><ForeName>Angelantonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Salerno, Baronissi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Molino</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Respiratory Division, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Candia</LastName><ForeName>Claudio</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, Respiratory Division, University of Naples Federico II, Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitale</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Salerno, Baronissi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hansbro</LastName><ForeName>Philip M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>Centre for Inflammation, School of Life Sciences, Faculty of Science, Centenary Institute and University of Technology Sydney, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vatrella</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Salerno, Baronissi, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pinto</LastName><ForeName>Aldo</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of Salerno, Fisciano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorrentino</LastName><ForeName>Rosalinda</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pharmacy, University of Salerno, Fisciano, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C410167">AIM2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002352">Carrier Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016898">Interferon-alpha</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.36</RegistryNumber><NameOfSubstance UI="D020170">Caspase 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002352" MajorTopicYN="N">Carrier Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020170" MajorTopicYN="N">Caspase 1</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="Y">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016898" MajorTopicYN="N">Interferon-alpha</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011658" MajorTopicYN="Y">Pulmonary Fibrosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AIM2 inflammasome</Keyword><Keyword MajorTopicYN="N">SARS&#x2013;CoV&#x2013;2</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword><Keyword MajorTopicYN="N">post-COVID-19 lung fibrosis</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>18</Day><Hour>3</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35844548</ArticleId><ArticleId IdType="pmc">PMC9277546</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.934264</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Colarusso C, Terlizzi M, Pinto A, Sorrentino R. A Lesson From a Saboteur: High-MW Kininogen Impact in Coronavirus-Induced Disease 2019. Br J Pharmacol (2020) 177:4866&#x2013;72. doi:&#xa0;10.1111/bph.15154</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15154</ArticleId><ArticleId IdType="pmc">PMC7300552</ArticleId><ArticleId IdType="pubmed">32497257</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W, Ni Z, Hu Y, Liang W, Ou C, He J. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med (2020) 382:1708&#x2013;20. doi:&#xa0;10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72,314 Cases From the Chinese Center for Disease Control and Prevention. JAMA (2020) 323:1239&#x2013;42. doi:&#xa0;10.1001/jama.2020.2648</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and Why Patients Made Long Covid. Soc Sci Med (2021) 268:113426. doi:&#xa0;10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>Davido B, Seang S, Tubiana R, de Truchis P. Post-COVID-19 Chronic Symptoms: A Postinfectious Entity? Clin Microbiol Infect (2020) 26(11):1448&#x2013;9. doi:&#xa0;10.1016/j.cmi.2020.07.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.07.028</ArticleId><ArticleId IdType="pmc">PMC7376333</ArticleId><ArticleId IdType="pubmed">32712242</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, Shen C, Wang L, Majumder S, Zhang D, Deen MJ, et al. . Pulmonary Fibrosis and its Related Factors in Discharged Patients With New Corona Virus Pneumonia: A Cohort Study. Respir Res (2021) 22:203. doi:&#xa0;10.1186/s12931-021-01798-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-021-01798-6</ArticleId><ArticleId IdType="pmc">PMC8267229</ArticleId><ArticleId IdType="pubmed">34243776</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J, Xu X, Jiang L, Dua K, Hansbro PM, Liu G. SARS-CoV-2 Induces Transcriptional Signatures in Human Lung Epithelial Cells That Promote Lung Fibrosis. Respir Res (2020) 21(1):182. doi:&#xa0;10.1186/s12931-020-01445-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01445-6</ArticleId><ArticleId IdType="pmc">PMC7359430</ArticleId><ArticleId IdType="pubmed">32664949</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Philp AM, Corte T, Travis MA, Schilter H, Hansbro NG, et al. . Therapeutic Targets in Lung Tissue Remodelling and Fibrosis. Pharmacol Ther (2021) 225:107839. doi:&#xa0;10.1016/j.pharmthera.2021.107839</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2021.107839</ArticleId><ArticleId IdType="pubmed">33774068</ArticleId></ArticleIdList></Reference><Reference><Citation>Terlizzi M, Molino A, Colarusso C, Donovan C, Imitazione P, Somma P, et al. . Activation of the Absent in Melanoma 2 Inflammasome in Peripheral Blood Mononuclear Cells From Idiopathic Pulmonary Fibrosis Patients Leads to the Release of Pro-Fibrotic Mediators. Front Immunol (2018) 9:670. doi:&#xa0;10.3389/fimmu.2018.00670</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00670</ArticleId><ArticleId IdType="pmc">PMC5895962</ArticleId><ArticleId IdType="pubmed">29675024</ArticleId></ArticleIdList></Reference><Reference><Citation>Donovan C, Kim RY, Galvao I, Jarnicki AG, Brown AC, Freeman BJ, et al. . Aim2 Suppresses Cigarette Smoke-Induced Neutrophil Recruitment, Caspase-1 Activation and Anti-Ly6Gmediated Neutrophil Depletion. Immunol Cell Biol (2022) 100(4):235&#x2013;49. doi:&#xa0;10.1111/imcb.12537</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imcb.12537</ArticleId><ArticleId IdType="pmc">PMC9545917</ArticleId><ArticleId IdType="pubmed">35175629</ArticleId></ArticleIdList></Reference><Reference><Citation>Colarusso C, Maglio A, Terlizzi M, Vitale C, Molino A, Pinto A, et al. . Post-COVID-19 Patients Who Develop Lung Fibrotic-Like Changes Have Lower Circulating Levels of IFN-&#x3b2; But Higher Levels of IL-1&#x3b1; and TGF-&#x3b2;. Biomedicines (2021) 9(12):1931. doi:&#xa0;10.3390/biomedicines9121931</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9121931</ArticleId><ArticleId IdType="pmc">PMC8698335</ArticleId><ArticleId IdType="pubmed">34944747</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen MD, Irving A, Montagutelli X, Tate MD, Rudloff I, Nold MF, et al. . Animal and Translational Models of SARS-CoV-2 Infection and COVID-19. Mucosal Immunol (2020) 13:877&#x2013;91. doi:&#xa0;10.1038/s41385-020-00340-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41385-020-00340-z</ArticleId><ArticleId IdType="pmc">PMC7439637</ArticleId><ArticleId IdType="pubmed">32820248</ArticleId></ArticleIdList></Reference><Reference><Citation>Terlizzi M, Di Crescenzo V, Perillo G, Galderisi A, Pinto A, Sorrentino R. Pharmacological Inhibition of Caspase-8 Limits Lung Tumour Outgrowth. Br J Pharmacol (2014) 172(15):3917&#x2013;28. doi:&#xa0;10.1111/bph.13176</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13176</ArticleId><ArticleId IdType="pmc">PMC4523345</ArticleId><ArticleId IdType="pubmed">25917370</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim RY, Pinkerton JW, Gibson PG, Cooper MA, Horvat JC, Hansbro PM. Inflammasomes in COPD and Neutrophilic Asthma. Thorax (2015) 70(12):1199&#x2013;201. doi:&#xa0;10.1136/thoraxjnl-2014-206736</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2014-206736</ArticleId><ArticleId IdType="pubmed">26493990</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Liu Y, Huang Z, Xu W, Hu W, Yi L, et al. . SARS-CoV-2 non-Structural Protein 6 Triggers NLRP3-Dependent Pyroptosis by Targeting ATP6AP1. Cell Death Differ (2022). doi:&#xa0;10.1038/s41418-021-00916-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41418-021-00916-7</ArticleId><ArticleId IdType="pmc">PMC9177730</ArticleId><ArticleId IdType="pubmed">34997207</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng J, Xiaochun X, Xiao-Li F, Jian-Bao H, Dandan Y, et al. . Specific Inhibition of the NLRP3 Inflammasome Suppresses Immune Overactivation and Alleviates COVID-19 Like Pathology in Mice. EBioMedicine (2022) 75:103803. doi:&#xa0;10.1016/j.ebiom.2021.103803</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103803</ArticleId><ArticleId IdType="pmc">PMC8719059</ArticleId><ArticleId IdType="pubmed">34979342</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow CS, Lee LH, Ramachandran DS, Hasan SS, Ming LC, Goh HP. The Effect of Colchicine on Mortality Outcome and Duration of Hospital Stay Patients With COVID-19: A Meta-Analysis of Randomized Trials. Immun Inflammation Dis (2022) 10(2):255&#x2013;64. doi:&#xa0;10.1002/iid3.562</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iid3.562</ArticleId><ArticleId IdType="pmc">PMC8767506</ArticleId><ArticleId IdType="pubmed">34970856</ArticleId></ArticleIdList></Reference><Reference><Citation>Colarusso C, Terlizzi M, Molino A, Imitazione P, Somma P, Rega R, et al. . AIM2 Inflammasome Activation Leads to IL-1&#x3b1; and TGF-&#x3b2; Release From Exacerbated Chronic Obstructive Pulmonary Disease-Derived Peripheral Blood Mononuclear Cells. Front Pharmacol (2019) 10:257. doi:&#xa0;10.3389/fphar.2019.00257</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00257</ArticleId><ArticleId IdType="pmc">PMC6428726</ArticleId><ArticleId IdType="pubmed">30930781</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorrentino R, Terlizzi M, Di Crescenzo V, Popolo A, Pecoraro M, Perillo G, et al. . Human Lung Cancer-Derived Immunosuppressive Plasmacytoid Dendritic Cells Release IL-1&#x3b1; in an AIM2 Inflammasome-Dependent Manner. Am J Pathol (2015) 185(11):3115&#x2013;24. doi:&#xa0;10.1016/j.ajpath.2015.07.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajpath.2015.07.009</ArticleId><ArticleId IdType="pubmed">26506473</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariazi EA, Cunliffe HE, Lewis-Wambi JS, Slifker MJ, Willis AL, Ramos P, et al. . Estrogen Induces Apoptosis in Estrogen Deprivation-Resistant Breast Cancer Through Stress Responses as Identified by Global Gene Expression Across Time. Proc Natl Acad Sci USA (2011) 108(47):18879&#x2013;86. doi:&#xa0;10.1073/pnas.1115188108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1115188108</ArticleId><ArticleId IdType="pmc">PMC3223472</ArticleId><ArticleId IdType="pubmed">22011582</ArticleId></ArticleIdList></Reference><Reference><Citation>Molino A, Terlizzi M, Colarusso C, Rossi A, Somma P, Saglia A, et al. . AIM2/IL-1&#x3b1;/TGF-&#x3b2; Axis in PBMCs From Exacerbated Chronic Obstructive Pulmonary Disease (COPD) Patients is Not Related to COX-2-Dependent Inflammatory Pathway. Front Physiol (2019) 10:1235. doi:&#xa0;10.3389/fphys.2019.01235</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.01235</ArticleId><ArticleId IdType="pmc">PMC6780005</ArticleId><ArticleId IdType="pubmed">31632288</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YC, Yu CJ, Chang SC, Galvin JR, Liu H, Hsiao C, et al. . Pulmonary Sequelae in Convalescent Patients After Severe Acute Respiratory Syndrome: Evaluation With Thin-Section CT. Radiology (2005) 236:1067&#x2013;75. doi:&#xa0;10.1148/radiol.2363040958</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2363040958</ArticleId><ArticleId IdType="pubmed">16055695</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan F, Ye T, Sun P, Gui S, Liang B, Li L, et al. . Time Course of Lung Changes at Chest CT During Recovery From Coronavirus Disease 2019 (COVID-19). Radiology (2020) 295:715&#x2013;21. doi:&#xa0;10.1148/radiol.2020200370</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200370</ArticleId><ArticleId IdType="pmc">PMC7233367</ArticleId><ArticleId IdType="pubmed">32053470</ArticleId></ArticleIdList></Reference><Reference><Citation>Unterholzner L. The Interferon Response to Intracellular DNA: Why So Many Receptors? Immunobiology (2013) 218(11):1312&#x2013;21. doi:&#xa0;10.1016/j.imbio.2013.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2013.07.007</ArticleId><ArticleId IdType="pubmed">23962476</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun L, Wu J, Du F, Chen X, Chen ZJ. Cyclic GMP-AMP Synthase is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway. Science (2013) 339:786&#x2013;91. doi:&#xa0;10.1126/science.1232458</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1232458</ArticleId><ArticleId IdType="pmc">PMC3863629</ArticleId><ArticleId IdType="pubmed">23258413</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie MJ, Irving AT, Forster SC, Marsland BJ, Hansbro PM, Hertzog PJ, et al. . Of Bats and Men: Immunomodulatory Options for COVID-19 Guided by the Immunopathology of SARS-CoV-2 Infection. Sci Immunol (2021) 6(63):eabd205. doi:&#xa0;10.1126/sciimmunol.abd0205</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abd0205</ArticleId><ArticleId IdType="pubmed">34533977</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Nicol&#xe1;s O, V&#x2019;kovski P, Zettl F, Zimmer G, Thiel V, Summerfield A. No Evidence for Human Monocyte-Derived Macrophage Infection and Antibody-Mediated Enhancement of SARS-CoV-2 Infection. Front Cell Infect Microbiol (2021) 11:644574. doi:&#xa0;10.3389/fcimb.2021.644574</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.644574</ArticleId><ArticleId IdType="pmc">PMC8072125</ArticleId><ArticleId IdType="pubmed">33912475</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues TS, de S&#xe1; KSG, Ishimoto AY, Becerra A, Oliveira S, Almeida L, et al. . Inflammasomes are Activated in Response to SARS-CoV-2 Infection and are Associated With COVID-19 Severity in Patients. J Exp Med (2021) 218:e20201707. doi:&#xa0;10.1084/jem.20201707</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20201707</ArticleId><ArticleId IdType="pmc">PMC7684031</ArticleId><ArticleId IdType="pubmed">33231615</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsen MD, de Graaf EL, Sonneveld ME, Plomp HR, Nouta J, Hoepel W, et al. . Afucosylated IgG Characterizes Enveloped Viral Responses and Correlates With COVID-19 Severity. Science (2021) 371(6532):eabc8378. doi:&#xa0;10.1126/science.abc8378</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8378</ArticleId><ArticleId IdType="pmc">PMC7919849</ArticleId><ArticleId IdType="pubmed">33361116</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty S, Gonzalez J, Edwards K, Mallajosyula V, Buzzanco AS, Sherwood R, et al. . Proinflammatory IgG Fc Structures in Patients With Severe COVID-19. Nat Immunol (2021) 22(1):67&#x2013;73. doi:&#xa0;10.1038/s41590-020-00828-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-00828-7</ArticleId><ArticleId IdType="pmc">PMC8130642</ArticleId><ArticleId IdType="pubmed">33169014</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilliams M Mildner A Yona S. Developmental and Functional Heterogeneity of Monocytes. Immunity (2018) 49(4):595&#x2013;613. doi:&#xa0;10.1016/j.immuni.2018.10.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.10.005</ArticleId><ArticleId IdType="pubmed">30332628</ArticleId></ArticleIdList></Reference><Reference><Citation>Svensson A, Patzi Churqui M, Schl&#xfc;ter K, Lind L, Eriksson K. Maturation-Dependent Expression of AIM2 in Human B-Cells. PloS One (2017) 12(8):e0183268. doi:&#xa0;10.1371/journal.pone.0183268</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0183268</ArticleId><ArticleId IdType="pmc">PMC5557365</ArticleId><ArticleId IdType="pubmed">28809949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kvedaraite E, Hertwig L, Sinha I, Ponzetta A, Myrberg IH, Lourda M, et al. . Major Alterations in the Mononuclear Phagocyte Landscape Associated With COVID-19 Severity. Proc Natl Acad Sci USA (2021) 118(6):e2018587118. doi:&#xa0;10.1073/pnas.2018587118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2018587118</ArticleId><ArticleId IdType="pmc">PMC8017719</ArticleId><ArticleId IdType="pubmed">33479167</ArticleId></ArticleIdList></Reference><Reference><Citation>McNab F, Mayer-Barber K, Sher A, Wack A, O&#x2019;Garra A. Type I Interferons in Infectious Disease. Nat Rev Immunol (2015) 15:87&#x2013;103. doi:&#xa0;10.1038/nri3787</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3787</ArticleId><ArticleId IdType="pmc">PMC7162685</ArticleId><ArticleId IdType="pubmed">25614319</ArticleId></ArticleIdList></Reference><Reference><Citation>Berkman N, Goldstein RH, Breuer R. Bleomycin-Induced Lung Injury is Enhanced by Interferon- &#x3b1;. Life Sci (1997) 60:PL415&#x2013;421. doi:&#xa0;10.1016/s0024-3205(97)00332-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0024-3205(97)00332-9</ArticleId><ArticleId IdType="pubmed">9199490</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, et al. . Immunology of COVID-19: Current State of the Science. Immunity (2020) 52:910&#x2013;41. doi:&#xa0;10.1016/j.immuni.2020.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu G, Qi F, Li H, Yang Q, Wang H, Wang X, et al. . The Differential Immune Responses to COVID-19 in Peripheral and Lung Revealed by Single-Cell RNA Sequencing. Cell Discovery (2020) 6:73. doi:&#xa0;10.1038/s41421-020-00225-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-00225-2</ArticleId><ArticleId IdType="pmc">PMC7574992</ArticleId><ArticleId IdType="pubmed">33101705</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>